Considering the findings of Gutierres et al. [8], the use of the combination of 90 mg/kg curcumin and aminoguanidine with insulin in a minor dose appears as a potentially applicable therapeutic strategy to avoid hypoglycemia, as well as being capable to mitigate or even avoid the diabetic complications related to glycoxidative stress. This evidence concerns the gene INS and Hypoglycemia.